scutellarin has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, ZY; Huang, H; Li, H; Liu, C; Tang, QZ; Wang, L; Yan, L; Zhu, LH | 1 |
| Lu, YJ; Mei, DH; Pan, ZW; Wang, JH; Xu, CQ; Yang, BF; Zhang, R; Zhang, XY; Zhang, Y | 1 |
2 other study(ies) available for scutellarin and Cardiomegaly
| Article | Year |
|---|---|
Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
Topics: Animals; Blood Pressure; Blotting, Western; Cardiomegaly; Cells, Cultured; Echocardiography; Electrophoretic Mobility Shift Assay; Flavonoids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Phosphorylation; Protein Kinase C-alpha; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad2 Protein; Smad3 Protein | 2010 |
Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways.
Topics: Animals; Animals, Newborn; Apigenin; Calcineurin; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cell Size; Cells, Cultured; Drugs, Chinese Herbal; Glucuronates; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phenylephrine; Rats; Rats, Wistar; Signal Transduction; Vasodilator Agents | 2010 |